Webinar Invite from Breast Cancer Foundation

You are invited to register to attend our upcoming webinar, Palbociclib (Ibrance) for metastatic ER+ breast cancer – NZ updatepresented by Breast Cancer Foundation NZ with Dr Richard Finn (USA).

More information on the panel and how to register can be found below.

The details

When: Monday March 19th, 2018

Time: 1.30-2.30pm

Duration: 60 minutes

Where: Online – wherever you like!

Presented by:
Breast Cancer Foundation NZ

If you can’t view the ‘Register now’ button above, please click here to register. 

Meet your panel

Dr Richard Finn, is associate professor of Medicine at the UCLA David Geffen School of Medicine. He led the PALOMA series of clinical trials for palbociclib and is considered one of the world’s foremost experts on this new drug.

We also hope to have a NZ oncologist on the panel, but this is yet to be confirmed.

What will you get out of this session?

This session will give you a run-down on what palbociclib is, how it works and who for; where it sits among treatments for advanced ER+ breast cancer; opportunities in NZ for clinical trials and compassionate access to palbociclib; paying privately, and discussing palbociclib with your oncologist

We look forward to you joining us online.

Breast Cancer Foundation NZ